Академический Документы
Профессиональный Документы
Культура Документы
Adheren
ce
in Mental Health
A Quality Improvement Project
by
Jon Webber, Jon Dimaya, Jon Onigama
and Christina Post
mental illness
refuse their medications?
1. Anosognosia: The person is unaware of their illness and does not think they are sick.
2. Alcohol and/or drug abuse
3. Poor relationships with mental health provider
4. Medication side effects
Nonadherence among patients with severe mental illness has been estimated
to be between 30% and 65%.
The following non-adherence rates have been reported: 30% to 66% for major
depression, 30% to 65% for bipolar disorder, and 40% to 50% for
schizophrenia (Pharmacy Today, 2013). According to 2013 State of the States:
Adherence Report by CVS Health, the percent of Hawaii patients with
depression that refilled their prescriptions after the first fill is about 30.8%.
Methods of Medcompliance
Reinforcement: Increases behavior
Positive: giving something (money, benefits, food, privileges) to
reward behavior
Negative: taking something away (money, benefits, food,
privileges) to discourage behavior
Escape: taking noxious stimuli away (release from restraints)
Active avoidance: behavior avoids noxious stimulant (avoiding
other patients to avoid confrontation)
Punishment: Decreases behavior
Positive: Add noxious stimuli to decrease behavior
(physical/chemical restraints)
Negative: Remove stimulus following behavior (send patient to
their room)
Collecting Data
Med-compliance data can be collected from the medical administration record
(MAR) of mental health facilities because it is documented that a patient:
complied to medical treatment
refused medical treatment
Data should be collected prior to initiating the tool.
The Daily Points Tool should be implemented for 2 months before collecting data a
2nd time to:
allow certain medications to reach therapeutic effects (SSRIs, TCAs, MAOIs)
allow time to observe med-compliance from acute and residential settings
allow time to observe outcomes of med-compliance (behavior, treatment
progress, patient insight/judgment, patient discharge status)
PDS
A
References
Aldridge, M. (2011). Addressing non-adherence to antipsychotic medication: a harm reduction approach. Journal of Psychiatric and
Mental Health Nursing, 1-12.
American Pharmacists Association. (2013). Improving medication adherence in patients with severe mental illness. Pharmacy Today,
19(6), 69-80.
Barnett, P.G., Sorensen, J.L., Wong, W., Haug, N.A., Hall, S.M. (2009). Effect of incentives for medication adherence on health care use
and costs in methadone patients with hiv. Drug and Alcohol Dependence, 100(1-2), 115-121.
Brankovic, S. (2015). Boredom, dopamine, and the thrill of psychosis: psychiatry in a new key. Psychiatria Danubina, 27(2), 126-137.
CVS Health. (2013). SOS Adherence Report 2013. Retrieved from CVShealth.com: http://cvshealth.com/sites/default/files/SOSAdherence-Report-2013_Final_2.pdf
Insel, I., Reinen, J., Weber, J., Wager, T.D., Jarskog, L.F., Shohamy, D., & Smith, E.E. (2014). Antipsychotic dose modulates behavior
and neural responses to feedback during reinforcement learning in schizophrenia. Cognitive, Affective, and Behavioral Neuroscience,
14(1), 189-201.
Kane, J., Kishimoto, T., & Correll, C. (2013). Non-adherence to medication in patients with psychotic disorders: epidemiology,
contributing factors and management strategies. World Psychiatry, 12(3), 216-226.